Kim, S. Y., Jin, C., Kim, C. H., Yoo, Y. H., Choi, S. H., Kim, G., . . . Choi, Y. H. (2019). Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation. Int J Mol Med.
Stile di citazione ChicagoKim, Shin Young, Cheng-Yun Jin, Cheol Hong Kim, Young Hyun Yoo, Sung Hyun Choi, Gi-Young Kim, Hyun Min Yoon, Hwan Tae Park, e Yung Hyun Choi. "Isorhamnetin Alleviates Lipopolysaccharide-induced Inflammatory Responses in BV2 Microglia By Inactivating NF-κB, Blocking the TLR4 Pathway and Reducing ROS Generation." Int J Mol Med 2019.
Citazione MLAKim, Shin Young, et al. "Isorhamnetin Alleviates Lipopolysaccharide-induced Inflammatory Responses in BV2 Microglia By Inactivating NF-κB, Blocking the TLR4 Pathway and Reducing ROS Generation." Int J Mol Med 2019.